TITLE:
      Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
SUMMARY:
      The purpose of this study is to compare subject response to liquid vs. tablet formulations,
      to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to
      evaluate if dose response curve for tablet is equal to liquid form."
DETAILED DESCRIPTION:
      1) Compare subjects response to liquid vs tablet formulation 2) Assess bioequivalency of
      liquid vs tablet 3)Compare subject preference 4) Evaluate if dose response curve for tablet
      = to liquid form
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F ages 18-65. Meet DMS-IV criteria for opiate dependence. Agree to conditions of the
        study and sign informed consent.

        Exclusion Criteria:

        Pregnant or nursing women. Acute medical condition that would interfere with study
        participation or put safety of subjects in jeopardy. Current daily use of
        anti-convulsants, antabuse or neuroleptics. DSM-IV diagnosis of ETOH or sedative/hypnotics
        dependence.
